This study determined the prevalence of Rheumatoid arthritis in elderly people that attended pilgrimage center, Elele Rivers state, Nigeria. A total of 200 subjects attending the pilgrimage center were examined for Rhematoid Factor using Latex agglutination method. The data was subjected to statistical analysis using Statistical Package for Social Sciences (SPSS) version 16.0. A prevalence of 4% was seen in the female subjects within the age bracket of 65-80 years and a prevalence of 1% was seen in the male subjects within the age bracket of 61-70 years. It showed that Rheumatoid arthritis was positive in 5% of the population and negative in 95% of the population, which was statistically significant (p< 0.05). In conclusion, there is a significant increase in the overall prevalence of rheumatoid arthritis in elderly subjects that attend pilgrimage center, Elele. Therefore proper care should be instituted to avoid unnecessary complications associated with this ailment.
O. O. Adelowo, O. Ojo, I. Oduenyi, and C. C. Okwara, “Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic”, Clinical Rheumatology, vol. 29 (6), pp. 593-597, 2011.
D. Antin-Ozerkis, J. Evans, A, Rubinowitz, R. J. Homer, and R. A. Matthay, “Pulmonary manifestations of rheumatoid arthritis”, Clinics in Chest Mediciine, vol. 31(14), pp. 451-478, 2010.
J. A. Aviña-Zubieta, H. K. Choi, M. Sadatsafavi, M. Etminan, J. M. Esdaile and D. Lacaille, “Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies”, Arthritis and Rheumatism, vol. 59(12), pp. 1690-1697, 2008.
H. F. Bastian, “Therapeutic strategies in rheumatoid arthritis”, Internist, vol. 52 (6), pp. 645-656, 2011.
P. Beighton, L. Solomon and H. A. Valkenburg, “Rheumatoid arthritis in a rural South African Negro population”, Annals of Rheumatologic Discussions, vol. 34(2), pp. 136-141, 1975.
S. W. Brighton, A. L. de la Harpe, D. J. van Staden, J. H. Badenhorst and O. L. Myers, “The prevalence of rheumatoid arthritis in a rural African population”, Journal of Rheumatology, vol. 15(3), pp. 405-408, 1988.
Y. G. Chiu & C.T. Ritchlin, “Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis” Expert Opinion on Biological Therapy, vol. 17(1), pp. 119-128, 2017.
B. Dowan, R.M. Campbell, L. Zgaga, D. Adeloye and K.Y. Chan, “Estimating the burden of rheumatoid arthritis in Africa”, The Journal of Global Health, vol. 2(2), pp. 020-406, 2012.
G. S. Firestein, “Evolving concepts of rheumatoid arthritis”, Nature, vol. 423(6937), pp. 356-361, 2003.
A. Gupta and& B. Fomberstein, “Evaluating cardiovascular risk in rheumatoid arthritis”, Journal of Musculoskeletal Medicine, vol. 26(8), pp. 481-494, 2009.
M. Kaddu-Mukasa, E. Ssekasanvu, E. Ddumba, D. Thomas and E.T. Katabira, “Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago Hospital”, African Health Science, vol. 11(1), pp. 24-29, 2011.
K. P. Liao and D.H. Solomon, “Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis”, Rheumatology, vol. 52, pp. 45-52, 2013.
J. J. Malemba, J. M. Mbuyi-Muamba, J. Mukaya, X. Bossuyt, M. P. Emonds, K. Deiteren and J. Muamba, “The phenotype and genotype of rheumatoid arthritis in the Democratic Republic of Congo”, Arthritis Research Therapy, vol. 15(4), pp. 89-92, 2013.
J. J. Malemba, J. Mbuyi-Muamba, J. Mukaya, X. Bossuyt, P. Verschueren, R. Westhovens and R.M. Campbell, “The epidemiology of rheumatoid arthritis in Kinshasa, Democratic Republic of Congo—a population-based study”, Rheumatology (Oxford), vol. 51(9), pp. 1644-1647, 2012.
O. L. Meyers, S. Jessop, and P. Klemp, “The epidemiology of rheumatic disease in a rural and an urban population over the age of 65 years”, South African Medicial Journal, vol. 62(12), pp. 403-405, 1982.
J. D. Moolenburgh, H. A. Valkenburg, and P. B. Fourie, “A population study on rheumatoid arthritis in Lesotho, southern Africa”, Annals of Rheumatologic Discussions, vol. 45(8), p. 691-695, 1986.
K. Nishimura, D. Sugiyama, Y. Kogata, G. Tsuji, T. Nakazawa, S. Kawano & S. Kumagai, “Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthriti"s”, Annals of Internal Medicine, vol. 146(11), pp. 797-808, 2007.
B. Shah and A. Ankur, Harrison's Principles of Internal Medicine (18th edition), United States: McGraw Hill. 2012, p. 324-327.
M. Singwe-Ngandeu, J. Meli, H. Ntsiba, C. Nouedoui, A. V. Yollo, M. B. Sida and D. Thomas, “Rheumatic diseases in patients attending a clinic at a referral hospital in Yaounde, Cameroon”, Eastern Africa Medical Journal, vol. 84(9),pp. 404-409, 2007.
S. Slimani and A. Ladjouze-Rezig, “Prevalence of rheumatoid arthritis in an urban population of Algeria: a prospective study”, Rheumatology, vol. 53(3), pp. 571-573, 2014.
J. S. Smolen, D. Aletaha and I. B. McInnes, “Rheumatoid arthritis”, The Lancet, vol. 388(10055), pp. 2023-2038, 2016.
D. H. Solomon, N. J. Goodson, J. N. Katz, M. E. Weinblatt, J. Avorn, and S.A. Setoguchi, “Patterns of cardiovascular risk in rheumatoid arthritis”, Annals of the Rheumatic Diseases, vol. 65(12), pp. 1608-1612, 2006.
L. Solomon, G. Robin and H.A. Valkenburg, “Rheumatoid arthritis in an urban South African Negro population” Annals of Rheumatologic Discussion, vol. 34(2), pp. 128-135, 1975.
L. Solomon, H. A. Valkenburg, P. Beighton, G. Robin and C. L. Soskolne, “Rheumatic disorders in the South African Negro. Part I. Rheumatoid arthritis and ankylosing spondylitis”, South African Medical Journal, vol. 49(32), pp. 1292-1296, 1975.
O. M. Westwood, P. N. Nelson and F. C. Hay, “Rheumatoid factors: what's new?”, Rheumatology, vol. 45(4), pp. 379-385, 2006.
F. Wolfe, D. M. Mitchell, J. T. Sibley, J. F. Fries, D. A. Bloch, C. A. Williams and M. A. Cathey, “The mortality of rheumatoid arthritis” Arthritis and Rheumatism, vol. 37(4), pp. 481-494, 1994.
This work is licensed under a Creative Commons Attribution 4.0 International License.